Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Record History shows several updates to Study Status and Recruitment Status across multiple versions, reflecting changes in the trial’s progress. These entries capture core details about the trial’s current and past activity.
    Difference
    0.1%
    Check dated 2025-11-03T13:45:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Updates introduce a new version (v3.2.0) and a government-operating status notice regarding NIH Clinical Center operations, replacing the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-06T02:15:37.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-28T23:26:12.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. Additionally, the 'Back to Top' element was removed, with no changes to core content, pricing, stock, or time slot availability.
    Difference
    0.8%
    Check dated 2025-09-14T09:54:01.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.8%
    Check dated 2025-09-07T07:56:43.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-31T01:08:20.000Z thumbnail image

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.